Albert David Limited (BOM:524075)
India · Delayed Price · Currency is INR 871.60
+1.30 (0.15%)
At close: Sep 25, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 4.97 billion as of September 25, 2026. Its market cap has increased by 9.58% in one year.
Market Cap
4.97B
Enterprise Value
2.69B
Revenue
3.64B
Ranking
n/a
PE Ratio
22.04
Stock Price
871.60
ChartMarket Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.97B, an increase of 6,081.56%. That is a compound annual growth rate of 18.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.97B | 17.78% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anuh Pharma | 9.05B |
| Wanbury | 7.83B |
| Kilitch Drugs (India) | 7.82B |
| ZIM Laboratories | 7.41B |
| Trident Lifeline | 4.87B |
| Medicamen Biotech | 4.33B |
| Jenburkt Pharmaceuticals | 4.19B |
| Astonea Labs | 3.55B |